Molecular basis for gene-specific transactivation by nuclear receptors

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 8, 2011, Pages 824-835

  Aagaard, Mads M ^a   Siersbæk, Rasmus ^a   Mandrup, Susanne ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Chromatin; Co factor interaction; DNA binding; DNA looping; Nuclear receptor specificity; Nuclear receptor structure

Indexed keywords

CELL NUCLEUS RECEPTOR; DNA; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; ZINC FINGER PROTEIN;

ALPHA HELIX; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHROMATIN; DNA SEQUENCE; HUMAN; LIGAND BINDING; LIGAND BINDING DOMAIN; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSACTIVATION; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; BINDING SITES; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECEPTOR CROSS-TALK; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTIONAL ACTIVATION;

METAZOA;

EID: 79958286397     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.12.018     Document Type: Review

References (163)

1. Altucci L., Gronemeyer H. Nuclear receptors in cell life and death. Trends Endocrinol. Metab. 2001, 12:460-468.
2. Werman Ariel, Hollenberg Anthony, Solanes Gemma, Bjørbæk Christian, Vidal-Puig Antonio J., Flier Jeffrey S., Activation Ligand-independent Domain in the N terminus of peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 1997, 272:20230-20235.
3. Bain D.L., Heneghan A.F., Connaghan-Jones K.D., Miura M.T. Nuclear receptor structure: implications for function. Annu. Rev. Physiol. 2007, 69:201-220.
4. Barry J.B., Giguere V. Epiderma growth factor-induced signaling in breast cancer cells resufts in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha. Cancer Res. 2005, 65:6120-6129.
5. Barry J.B., Laganiere J., Giguere V. A single nucleotide in an estrogen-related receptor alpha site can dictate mode of binding and peroxisome proliferator-activated receptor gamma coactivator 1 alpha activation of target promoters. Mol. Endocrinol. 2006, 20:302-310.
6. Baumann C.T., Lim C.S., Hager G.L. Intracellular localization and trafficking of steroid receptors. Cell Biochem. Biophys. 1999, 31:119-127.
7. Baumann C.T., Maruvada P., Hager G.L., Yen P.M. Nuclear cytoplasmic shuttling by thyroid hormone receptors - multiple protein interactions are required for nuclear retention. J. Biol. Chem. 2001, 276:11237-11245.
8. Belikov S., Astrand C., Wrange O. FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter. Mol. Cell. Biol. 2009, 29:5413-5425.
9. Berrevoets C.A., Doesburg P., Steketee K., Trapman J., Brinkmann A.O. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2). Mol. Endocrinol. 1998, 12:1172-1183.
10. Biddie S.C., Hager G.L. Glucocorticoid receptor dynamics and gene regulation. Stress Int. J. Biol. Stress 2009, 12:193-205.
11. Blind R.D., Garabedian M.J. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J. Steroid Biochem. Mol. Biol. 2008, 109:150-157.
12. Bosisio D., Marazzi I., Agresti A., Shimizu N., Bianchi M.E., Natoli G. A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappa B-dependent gene activity. EMBO J. 2006, 25:798-810.
13. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-[alpha]. Nature 1995, 375:377-382.
14. Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389:753-758.
15. Bugge A., Grontved L., Aagaard M.M., Borup R., Mandrup S. The PPAR gamma 2 A/B-domain plays a gene-specific role in transactivation and cofactor recruitment. Mol. Endocrinol. 2009, 23:794-808.
16. Bugge A., Siersbaek M., Madsen M.S., Göndör A., Rougier C., Mandrup S. A novel intronic peroxisome proliferator activated receptor (PPAR) gamma enhancer in the uncoupling protein (UCP) 3 gene as a regulator of both UCP2 and -3 expression in adipocytes. Journal of Biological Chemistry 2010, 285(23):17310-17317.
17. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W.L., Hestermann E.V., Geistlinger T.R., Fox E.A., Silver P.A., Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
18. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., Wang Q., Bekiranov S., Sementchenko V., Fox E.A., Silver P.A., Gingeras T.R., Liu X.S., Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 2006, 38:1289-1297.
19. Chandra V., Huang P.X., Hamuro Y., Raghuram S., Wang Y.J., Burris T.P., Rastinejad F. Structure of the intact PPAR-gamma-RXR-alpha nuclear receptor complex on DNA. Nature 2008, 456:350-356.
20. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995, 377:454-457.
21. Chen W.W., Dang T., Blind R.D., Wang Z., Cavasotto C.N., Hittelman A.B., Rogatsky I., Logan S.K., Garabedian M.J. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol. Endocrinol. 2008, 22:1754-1766.
22. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., Wong E., Orlov Y.L., Zhang W.W., Jiang J.M., Loh Y.H., Yeo H.C., Yeo Z.X., Narang V., Govindarajan K.R., Leong B., Shahab A., Ruan Y.J., Bourque G., Sung W.K., Clarke N.D., Wei C.L., Ng H.H. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
23. Cirillo L.A., Lin F.R., Cuesta I., Friedman D., Jarnik M., Zaret K.S. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 2002, 9:279-289.
24. Cohen R.N., Putney A., Wondisford F.E., Hollenberg A.N. The nuclear corepressors recognize distinct nuclear receptor complexes. Mol. Endocrinol. 2000, 14:900-914.
25. Metzger Daniel, Bornert Jean-Marc, Chambon Pierre Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J. Biol. Chem. 1995, 270:9535-9542.
26. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., Fletterick R.J., Yamamoto K.R. Structure and specificity of nuclear receptorGÇôcoactivator interactions. Genes Dev. 1998, 12:3343-3356.
27. Delaunay F., Pettersson K., Tujague M., Gustafsson J.A. Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. Mol. Pharmacol. 2000, 58:584-590.
28. Deroo B.J., Korach K.S. Estrogen receptors and human disease. J. Clin. Invest. 2006, 116:561-570.
29. Desvergne B., Heligon C. Steroid hormone pulsing drives cyclic gene expression. Nat. Cell Biol. 2009, 11:1051-1053.
30. Dong X., Challis J.R.G., Lye S.J. Intramolecular interactions between the AF3 domain and the C-terminus of the human progesterone receptor are mediated through two LXXLL motifs. J. Mol. Endocrinol. 2004, 32:843-857.
31. Eeckhoute J., Lupien M., Meyer C.A., Verzi M.P., Shivdasani R.A., Liu X.S., Brown M. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res. 2009, 19:372-380.
32. Evans R.M., Barish G.D., Wang Y.X. PPARs and the complex journey to obesity. Nat. Med. 2004, 10:355-361.
33. Fejes-Toth G., Pearce D., Naray-Fejes-Toth A. Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc. Natl Acad. Sci. USA 1998, 95:2973-2978.
34. Fletcher T.M., Xiao N.Q., Mautino G., Baumann C.T., Wolford R., Warren B.S., Hager G.L. ATP-dependent mobilization of the glucocorticoid receptor during chromatin remodeling. Mol. Cell. Biol. 2002, 22:3255-3263.
35. Freedman L.P., Luisi B.F., Korszun Z.R., Basavappa R., Sigler P.B., Yamamoto K.R. The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature 1988, 334:543-546.
36. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., Orlov Y.L., Velkov S., Ho A., Mei P.H., Chew E.G.Y., Huang P.Y.H., Welboren W.J., Han Y., Ooi H.S., Ariyaratne P.N., Vega V.B., Luo Y., Tan P.Y., Choy P.Y., Wansa K.D.S., Zhao B., Lim K.S., Leow S.C., Yow J.S., Joseph R., Li H., Desai K.V., Thomsen J.S., Lee Y.K., Karuturi R.K.M., Herve T., Bourque G., Stunnenberg H.G., Ruan X., Cacheux-Rataboul V., Sung W.K., Liu E.T., Wei C.L., Cheung E., Ruan Y. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
37. Garza A.M.S., Khan S.H., Kumar R. Site-specific phosphorylation induces functionally active conformation in the intrinsically disordered N-terminal activation function (AF1) domain of the glucocorticoid receptor. Mol. Cell. Biol. 2010, 30:220-230.
38. Gearhart M.D., Holmbeck S.M.A., Evans R.M., Dyson H.J., Wright P.E. Monomeric complex of human orphan estrogen related receptor-2 with DNA: a pseudo-dimer interface mediates extended half-site recognition. J. Mol. Biol. 2003, 327:819-832.
39. Georget V., Lobaccaro J.M., Terouanne B., Mangeat P., Nicolas J.C., Sultan C. Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor. Mol. Cell. Endocrinol. 1997, 129:17-26.
40. Gheldof N., Smith E.M., Tabuchi T.M., Koch C.M., Dunham I., Stamatoyannopoulos J.A., Dekker J. Cell-type-specific long-range looping interactions identify distant regulatory elements of the CFTR gene. Nucleic Acids Res. 2010, 38:4325-4336.
41. Giangrande P.H., Kimbrel E.A., Edwards D.P., McDonnell D.P. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol. Cell. Biol. 2000, 20:3102-3115.
42. Giguere V. Orphan nuclear receptors: from gene to function. Endocr. Rev. 1999, 20:689-725.
43. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000, 14:121-141.
44. Grad J.M., Lyons L.S., Robins D.M., Burnstein K.L. The androgen receptor (AR) amino-terminus imposes androgen-specific regulation of AR gene expression via an exonic enhancer. Endocrinology 2001, 142:1107-1116.
45. Jenster Guido Hetty A.G.M.van der Korput, Jan Trapman, Albert O. Brinkmann, Identification of Two Transcription Activation Units in the N-terminal of the Human Androgen Receptor. J. Biol. Chem. 1995, 270:7341-7346.
46. Haelens A., Verrijdt G., Callewaert L., Christiaens V., Schauwaers K., Peeters B., Rombauts W., Claessens F. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation. Biochem. J. 2003, 369:141-151.
47. Haelens A., Verrijdt G., Callewaert L., Peeters B., Rombauts W., Claessens F. Androgen-receptor-specific DNA binding to an element in the first exon of the human secretory component gene. Biochem. J. 2001, 353:611-620.
48. Hager G.L., McNally J.G., Misteli T. Transcription dynamics. Mol. Cell 2009, 35:741-753.
49. Hakim O., John S., Ling J.Q., Biddie S.C., Hoffman A.R., Hager G.L. Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions. J. Biol. Chem. 2009, 284:6048-6052.
50. Hard T., Kellenbach E., Boelens R., Maler B.A., Dahlman K., Freedman L.P., Carlstedt-Duke J., Yamamoto K.R., Gustafsson J.A., Kaptein R. Solution structure of the glucocorticoid receptor DNA-binding domain. Science 1990, 249:157-160.
51. Hawse J.R., Subramaniam M., Monroe D.G., Hemmingsen A.H., Ingle J.N., Khosla S., Oursler M.J., Spelsberg T.C. Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: An essential role for the activation function 1 domain. Mol. Endocrinol. 2008, 22:1579-1595.
52. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptor. Nature 1997, 387:733-736.
53. Heinz S., Benner C., Spann N., Bertolino E., Lin Y.C., Laslo P., Cheng J.X., Murre C., Singh H., Glass C.K. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
54. Hesselberth J.R., Chen X., Zhang Z., Sabo P.J., Sandstrom R., Reynolds A.P., Thurman R.E., Neph S., Kuehn M.S., Noble W.S., Fields S., Stamatoyannopoulos J.A. Global mapping of protein-DNA interactions in vivo by digital genomic footprinting. Nat. Meth. 2009, 6:283-289.
55. Hill K.K., Roemer S.C., Jones D.N.M., Churchill M.E.A., Edwards D.P. A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain. J. Biol. Chem. 2009, 284:24415-24424.
56. Hollenberg S.M., Evans R.M. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 1988, 55:899-906.
57. Hong W., Baniahmad A., Li J., Chang C.L., Gao W.Z., Liu Y.D. Bag-1M inhibits the transactivation of the glucocorticoid receptor via recruitment of corepressors. FEBS Lett. 2009, 583:2451-2456.
58. Hong W., Baniahmad A., Liu Y.D., Li H.Q. Bag-1M is a component of the in vivo DNA-glucocorticoid receptor complex at hormone-regulated promoter. J. Mol. Biol. 2008, 384:22-30.
59. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamel Y., Soderstrom M., Glass C.K., Rosenfeld M.G. Ligand-independent repression by the thyroid-hormone receptor-mediated by a nuclear receptor co-repressor. Nature 1995, 377:397-404.
60. Htun H., Barsony J., Renyi I., Gould D.L., Hager G.L. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc. Natl Acad. Sci. USA 1996, 93:4845-4850.
61. Hu X., Lazar M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 1999, 402:93-96.
62. Hummasti S., Tontonoz P. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis. Mol. Endocrinol. 2006, 20:1261-1275.
63. Jennewein C., Kuhn A.M., Schmidt M.V., Meilladec-Jullig V., von Knethen A., Gonzalez F.J., Brune B. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappa B binding sites proinflammatory cytokines. J. Immunol. 2008, 181:5646-5652.
64. Jeong B.C., Hong C.Y., Chattopadhyay S., Park J.H., Gong E.Y., Kim H.J., Chun S.Y., Lee K. Androgen receptor corepressor-19kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase. Mol. Endocrinol. 2004, 18:13-25.
65. John S., Sabo P.J., Johnson T.A., Sung M.H., Biddie S.C., Lightman S.L., Voss T.C., Davis S.R., Meltzer P.S., Stamatoyannopoulos J.A., Hager G.L. Interaction of the glucocorticoid receptor with the chromatin landscape. Mol. Cell 2008, 29:611-624.
66. Johnson T.A., Elbi C., Parekh B.S., Hager G.L., John S. Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter. Mol. Biol. Cell 2008, 19:3308-3322.
67. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C.B., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation - down-modulation of Ap-1 (Fos Jun) activity by glucocorticoid hormone. Cell 1990, 62:1189-1204.
68. Kaikkonen S., Jaaskelainen T., Karvonen U., Rytinki M.M., Makkonen H., Gioeli D., Paschal B.M., Palvimo J.J. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. Mol. Endocrinol. 2009, 23:292-307.
69. Kang Z.G., Pirskanen A., Janne O.A., Palvimo J.J. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem. 2002, 277:48366-48371.
70. Kangaspeska S., Stride B., Metivier R., Polycarpou-Schwarz M., Ibberson D., Carmouche R.P., Benes V., Gannon F., Reid G. Transient cyclical methylation of promoter DNA. Nature 2008, 452:112-115.
71. Karpova T.S., Kim M.J., Spriet C., Nalley K., Stasevich T.J., Kherrouche Z., Heliot L., McNally J.G. Concurrent fast and slow cycling of a transcriptional activator at an endogenous promoter. Science 2008, 319:466-469.
72. Klock G., Strahle U., Schutz G. Oestrogen and glucocorticoid responsive elements are closely related but distinct. Nature 1987, 329:734-736.
73. Klokk T.I., Kurys P., Elbi C., Nagaich A.K., Hendarwanto A., Slagsvold T., Chang C.Y., Hager G.L., Saatcioglu F. Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol. Cell. Biol. 2007, 27:1823-1843.
74. Knudsen K.E., Penning T.M. Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol. Metab. 2010, 21:315-324.
75. Kumar R., Betney R., Li J.Q., Thompson E.B., Mcewan I.J. Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF. Biochemistry 2004, 43:3008-3013.
76. Kumar R., Volk D.E., Li J.Q., Lee J.C., Gorenstein D.G., Thompson E.B. TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain. Proc. Natl Acad. Sci. USA 2004, 101:16425-16430.
77. Kurokawa R., Soderstrom M., Horlein A., Halachmi S., Brown M., Rosenfeld M.G., Glass C.K. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 1995, 377:451-454.
78. Langley E., Kemppainen J.A., Wilson E.M. Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. J. Biol. Chem. 1998, 273:92-101.
79. le Maire A., Teyssier C., Erb C., Grimaldi M., Alvarez S., de Lera A.R., Balaguer P., Gronemeyer H., Royer C.A., Germain P., Bourguet W. A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor. Nat. Struct. Mol. Biol. 2010, 17:801-807.
80. Lefterova M.I., Steger D.J., Zhuo D., Qatanani M., Mullican S.E., Tuteja G., Manduchi E., Grant G.R., Lazar M.A. Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages. Mol. Cell. Biol. 2010, 30:2078-2089.
81. Lefterova M.I., Zhang Y., Steger D.J., Schupp M., Schug J., Cristancho A., Feng D., Zhuo D., Stoeckert C.J., Liu X.S., Lazar M.A. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008, 22:2941-2952.
82. Li G.D., Thomas A.M., Hart S.N., Zhong X.B., Wu D.Q., Guo G.L. Farnesoid X receptor activation mediates head-to-tail chromatin looping in the Nr0b2 gene encoding small heterodimer partner. Mol. Endocrinol. 2010, 24:1404-1412.
83. Lightman S.L., Wiles C.C., Atkinson H.C., Henley D.E., Russell G.M., Leendertz J.A., McKenna M.A., Spiga F., Wood S.A., Conway-Campbell B.L. The significance of glucocorticoid pulsatility. Eur. J. Pharmacol. 2008, 583:255-262.
84. Lim C.S., Baumann C.T., Htun H., Xian W.J., Irie M., Smith C.L., Hager G.L. Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras. Mol. Endocrinol. 1999, 13:366-375.
85. Little T.H., Zhang Y.B., Matulis C.K., Weck J., Zhang Z.P., Ramachandran A., Mayo K.E., Radhakrishnan I. Sequence-specific deoxyribonucleic acid (DNA) recognition by steroidogenic factor 1: A helix at the carboxy terminus of the DNA binding domain is necessary for complex stability. Mol. Endocrinol. 2006, 20:831-843.
86. Liu Y., Gao H., Marstrand T.T., Strom A., Valen E., Sandelin A., Gustafsson J.A., Dahlman-Wright K. The genome landscape of ER alpha- and ER beta-binding DNA regions. Proc. Natl Acad. Sci. USA 2008, 105:2604-2609.
87. Liu Y., Xia X., Fondell J.D., Yen P.M. Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Mol. Endocrinol. 2006, 20:483-490.
88. Lonard D.M., O'Malley B.W. Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation. Mol. Cell 2007, 27:691-700.
89. Lupien M., Eeckhoute J., Meyer C.A., Wang Q.B., Zhang Y., Li W., Carroll J.S., Liu X.S., Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008, 132:958-970.
90. Mackem S., Baumann C.T., Hager G.L. A glucocorticoid/retinoic acid receptor chimera that displays cytoplasmic/nuclear translocation in response to retinoic acid - A real time sensing assay for nuclear receptor ligands. J. Biol. Chem. 2001, 276:45501-45504.
91. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P. G. Sch3tz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, R.M. Evans, The nuclear receptor superfamily: The second decade. Cell 1995, 83:835-839.
92. McInerney E.M., Weis K.E., Sun J., Mosselman S., Katzenellenbogen B.S. Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras. Endocrinology 1998, 139:4513-4522.
93. McNally J.G., Muller W.G., Walker D., Wolford R., Hager G.L. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 2000, 287:1262-1265.
94. Melvin V.S., Harrell C., Adelman J.S., Kraus W.L., Churchill M., Edwards D.P. The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB. J. Biol. Chem. 2004, 279:14763-14771.
95. Metivier R., Gallais R., Tiffoche C., Le Peron C., Jurkowska R.Z., Carmouche R.P., Ibberson D., Barath P., Demay F., Reid G., Benes V., Jeltsch A., Gannon F., Salbert G. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452:45-50.
96. Metivier R., Penot G., Flouriot G., Pakdel F. Synergism between ER alpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: Requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. Mol. Endocrinol. 2001, 15:1953-1970.
97. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
98. Michalik L., Desvergne B., Wahli W. Peroxisome-proliferator-activated receptors and cancers: complex stories. Nat. Rev. Cancer 2004, 4:61-70.
99. Mikkelsen T.S., Xu Z., Zhang X.L., Wang L., Gimble J.M., Lander E.S., Rosen E.D. Comparative Epigenomic Analysis of Murine and Human Adipogenesis. Cell 2010, 143:156-169.
100. Misteli T. Nuclear structure - protein dynamics: Implications for nuclear architecture and gene expression. Science 2001, 291:843-847.
101. Nader N., Chrousos G.P., Kino T. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J. 2009, 23:1572-1583.
102. Nagaich A.K., Walker D.A., Wolford R., Hager G.L. Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol. Cell 2004, 14:163-174.
103. Nielsen R., Pedersen T.Å., Hagenbeek D., Moulos P., Siersbæk R., Megens E., Denissov S., Børgesen M., Francoijs K.J., Mandrup S., Stunnenberg H.G. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev. 2008, 22:2953-2967.
104. Nishizawa H., Yamagata K., Shimomura L., Takahashi M., Kuriyama H., Kishida K., Hotta K., Nagaretani H., Maeda N., Matsuda M., Kihara S., Nakamura T., Nishigori H., Tomura H., Moore D.D., Takeda J., Funahashi T., Matsuzawa Y. Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation. J. Biol. Chem. 2002, 277:1586-1592.
105. Pan Y.F., Wansa K.D.S.A., Liu M.H., Zhao B., Hong S.Z., Tan P.Y., Lim K.S., Bourque G., Liu E.T., Cheung E. Regulation of estrogen receptor-mediated long range transcription via evolutionarily conserved distal response elements. J. Biol. Chem. 2008, 283:32977-32988.
106. Papoutsi Z., Zhao C.Y., Putnik M., Gustafsson J.A., Dahlman-Wright K. Binding of estrogen receptor alpha/beta heterodimers to chromatin in MCF-7 cells. J. Mol. Endocrinol. 2009, 43:65-72.
107. S. Paruthiyil, A. Cvoro, X.Y. Zhao, Z.J. Wu, Y.X. Sui, R.E. Staub, S. Baggett, C.B. Herber, C. Griffin, M. Tagliaferri, H.A. Harris, I. Cohen, L.F. Bjeldanes, T.P. Speed, F. Schaufele, D.C. Leitman, Drug and Cell Type-Specific Regulation of Genes with Different Classes of Estrogen Receptor beta-Selective Agonists, Plos One 4 (2009).
108. Pascual G., Fong A.L., Ogawa S., Gamliel A., Li A.C., Perissi V., Rose D.W., Willson T.M., Rosenfeld M.G., Glass C.K. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 2005, 437:759-763.
109. Payvar F., DeFranco D., Firestone G.L., Edgar B., Wrange Í., Okret S. J.+. Gustafsson, K.R. Yamamoto, Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 1983, 35:381-392.
110. Perissi V., Aggarwal A., Glass C.K., Rose D.W., Rosenfeld M.G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 2004, 116:511-526.
111. Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones A., Rose D.W., Lambert M.H., Milburn M.V., Glass C.K., Rosenfeld M.G. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 1999, 13:3198-3208.
112. Pettersson K., Grandien K., Kuiper G.G.J.M., Gustafsson J.A. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor {alpha}. Mol. Endocrinol. 1997, 11:1486-1496.
113. Phelan C.A., Gampe R.T., Lambert M.H., Parks D.J., Montana V., Bynum J., Broderick T.M., Hu X., Williams S.P., Nolte R.T., Lazar M.A. Structure of Rev-erb alpha bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interaction. Nat. Struct. Mol. Biol. 2010, 17:808-814.
114. Poukka H., Karvonen U., Janne O.A., Palvimo J.J. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl Acad. Sci. USA 2000, 97:14145-14150.
115. Pourcet B., Pineda-Torra I., Derudas B., Staels B., Glineur C. SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR. J. Biol. Chem. 2010, 285:5983-5992.
116. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 1997, 18:306-360.
117. Prufer K., Boudreaux J. Nuclear localization of liver X receptor alpha and beta is differentially regulated. J. Cell. Biochem. 2007, 100:69-85.
118. Rastinejad F. Retinoid X receptor and its partners in the nuclear receptor family. Curr. Opin. Struct. Biol. 2001, 11:33-38.
119. Rastinejad F., Perlmann T., Evans R.M., Sigler P.B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 1995, 375:203-211.
120. Rauch A., Seitz S., Baschant U., Schilling A.F., Illing A., Stride B., Kirilov M., Mandic V., Takacz A., Schmidt-Ullrich R., Ostermay S., Schinke T., Spanbroek R., Zaiss M.M., Angel P.E., Lerner U.H., David J.P., Reichardt H.M., Amling M., Schutz G., Tuckermann J.P. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 2010, 11:517-531.
121. Rayasam G.V., Elbi C., Walker D.A., Wolford R., Fletcher T.M., Edwards D.P., Hager G.L. Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol. Cell. Biol. 2005, 25:2406-2418.
122. Renaud J.P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-[gamma] ligand-binding domain bound to all-trans retinoic acid. Nature 1995, 378:681-689.
123. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 2002, 277:5209-5218.
124. Hi Rika, Osada Shiho, Yumoto Noburu, Osumi Takashi Characterization of the amino-terminal activation domain of the peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 1999, 274:35152-35158.
125. Roemer S.C., Donham D.C., Sherman L., Pon V.H., Edwards D.P., Churchill M.E.A. Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. Mol. Endocrinol. 2006, 20:3042-3052.
126. Rohs R., West S.M., Sosinsky A., Liu P., Mann R.S., Honig B. The role of DNA shape in protein-DNA recognition. Nature 2009, 461:1248-1253.
127. Ross-Innes C.S., Stark R., Holmes K.A., Schmidt D., Spyrou C., Russell R., Massie C.E., Vowler S.L., Eldridge M., Carroll J.S. Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev. 2010, 24:171-182.
128. Schmidt D., Wilson M.D., Ballester B., Schwalie P.C., Brown G.D., Marshall A., Kutter C., Watt S., Martinez-Jimenez C.P., Mackay S., Talianidis I., Flicek P., Odom D.T. Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding. Science 2010, 328:1036-1040.
129. Schoch G.A., D'Arcy B., Stihle M., Burger D., Bar D., Benz J., Thoma R., Ruf A. Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations. J. Mol. Biol. 2010, 395:568-577.
130. Schoenmakers E., Alen P., Verrijdt G., Peeters B., Verhoeven G., Rombauts W., Claessens F. Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains. Biochem. J. 1999, 341:515-521.
131. Schwabe J.W.R., Chapman L., Finch J.T., Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements. Cell 1993, 75:567-578.
132. Schwabe J.W.R., Neuhaus D., Rhodes D. Solution structure of the DMA-binding domain of the oestrogen receptor. Nature 1990, 348:458-461.
133. Shaffer P.L., Jivan A., Dollins D.E., Claessens F., Gewirth D.T. Structural basis of androgen receptor binding to selective androgen response elements. Proc. Natl Acad. Sci. USA 2004, 101:4758-4763.
134. Shang Y.F., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103:843-852.
135. Shao D.L., Rangwala S.M., Bailey S.T., Krakow S.L., Reginato M.J., Lazar M.A. Interdomain communication regulating ligand binding by PPAR-gamma. Nature 1998, 396:377-380.
136. Sharp Z.D., Mancini M.G., Hinojos C.A., Dai F., Berno V., Szafran A.T., Smith K.P., Lele T.T., Ingber D.E., Mancini M.A. Estrogen-receptor-alpha exchange and chromatin dynamics are ligand- and domain-dependent. J. Cell Sci. 2006, 119:4101-4116.
137. Shu F.J., Sidell N., Yang D.Z., Kallen C.B. The tri-nucleotide spacer sequence between estrogen response element half-sites is conserved and modulates ER alpha-mediated transcriptional responses. J. Steroid Biochem. Mol. Biol. 2010, 120:172-179.
138. Shulman A.I., Mangelsdorf D.J. Mechanisms of disease: Retinoid X receptor heterodimers in the metabolic syndrome. N. Engl. J. Med. 2005, 353:604-615.
139. So A.Y.-L., Chaivorapol C., Bolton E.C., Li H., Yamamoto K.R. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet. 2007, 3:e94.
140. Stavreva D.A., Muller W.G., Hager G.L., Smith C.L., McNally J.G. Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Mol. Cell. Biol. 2004, 24:2682-2697.
141. Stavreva D.A., Wiench M., John S., Conway-Campbell B.L., McKenna M.A., Pooley J.R., Johnson T.A., Voss T.C., Lightman S.L., Hager G.L. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat. Cell Biol. 2009, 11:1093-1102.
142. Steger D.J., Grant G.R., Schupp M., Tomaru T., Lefterova M.I., Schug J., Manduchi E., Stoeckert C.J., Lazar M.A. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev. 2010, 24:1035-1044.
143. Stella S., Cascio D., Johnson R.C. The shape of the DNA minor groove directs binding by the DNA-bending protein Fis. Genes Dev. 2010, 24:814-826.
144. Str Test U. article sample title placed here. Proc. Natl Acad. Sci. USA 1987, 84:7871-7875.
145. Tahirov T.H., Sato K., Ichikawa-Iwata E., Sasaki M., Inoue-Bungo T., Shiina M., Kimura K., Takata S., Fujikawa A., Morii H., Kumasaka T., Yamamoto M., Ishii S., Ogata K. Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter. Cell 2002, 108:57-70.
146. Takimoto G.S., Tung L., Abdel-Hafiz H., Abel M.G., Sartorius C.A., Richer J.K., Jacobsen B.M., Bain D.L., Horwitz K.B. Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure. J. Steroid Biochem. Mol. Biol. 2003, 85:209-219.
147. Tanner T., Denayer S., Geverts B., Tilborgh N., Kerkhofs S., Helsen C., Spans L., Dubois V., Houtsmuller A., Claessens F., Haelens A. A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels. Cell. Mol. Life Sci. 2010, 67:1919-1927.
148. Tremblay A., Vincent G. Contribution of steroid receptor coactivator-1 and CREB binding protein in ligand-independent activity of estrogen receptor beta. J. Steroid Biochem. Mol. Biol. 2001, 77:19-27.
149. Umesono K., Evans R.M. Determinants of Target Gene Specificity for Steroid Thyroid-Hormone Receptors. Cell 1989, 57:1139-1146.
150. Umesono K., Evans R.M. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 1989, 57:1139-1146.
151. Umesono K., Giguere V., Glass C.K., Rosenfeld M.G., Evans R.M. Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature 1988, 336:262-265.
152. Wagner R.L., Apriletti J.W., McGrath M.E., West B.L., Baxter J.D., Fletterick R.J. A structural role for hormone in the thyroid hormone receptor. Nature 1995, 378:690-697.
153. Wang Q.B., Li W., Liu X.S., Carroll J.S., Janne O.A., Keeton E.K., Chinnaiyan A.M., Pienta K.J., Brown M. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell 2007, 27:380-392.
154. Wardell S.E., Boonyaratanakornkit V., Adelman J.S., Aronheim A., Edwards D.P. Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. Mol. Cell. Biol. 2002, 22:5451-5466.
155. Wardell S.E., Kwok S.C., Sherman L., Hodges R.S., Edwards D.P. Regulation of the amino-terminal transcription activation domain of progesterone receptor by a cofactor-induced protein folding mechanism. Mol. Cell. Biol. 2005, 25:8792-8808.
156. Warnmark A., Wikstrom A., Wright A.P.H., Gustafsson J.A., Hard T. The N-terminal regions of estrogen receptor alpha and beta are unstructured in vitro and show different TBP binding properties. J. Biol. Chem. 2001, 276:45939-45944.
157. Webb P., Nguyen P., Shinsako J., Anderson C., Feng W.J., Nguyen M.P., Chen D.G., Huang S.M., Subramanian S., McKinerney E., Katzenellenbogen B.S., Stallcup M.R., Kushner P.J. Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol. Endocrinol. 1998, 12:1605-1618.
158. Wu C., Wong Y.C., Elgin S.C.R. Chromatin structure of specific genes: 2. Disruption of chromatin structure during gene activity. Cell 1979, 16:807-814.
159. Yangyen H.F., Chambard J.C., Sun Y.L., Smeal T., Schmidt T.J., Drouin J., Karin M. Transcriptional interference between c-jun and the glucocorticoid receptor - mutual inhibition of dna-binding due to direct protein protein-interaction. Cell 1990, 62:1205-1215.
160. Zechel C., Shen X.Q., Chambon P., Gronemeyer H. Dimerization interfaces formed between the dna-binding domains determine the cooperative binding of Rxr Rar and Rxr Tr heterodimers to Dr5 and Dr4 elements. EMBO J. 1994, 13:1414-1424.
161. Zechel C., Shen X.Q., Chen J.Y., Chen Z.P., Chambon P., Gronemeyer H. The dimerization interfaces formed between the DNA-binding domains of RXR. RAR and TR determine the binding-specificity and polarity of the full-length receptors to direct repeats. EMBO J. 1994, 13:1425-1433.
162. Zhu X.G., Hanover J.A., Hager G.L., Cheng S.Y. Hormone-induced translocation of thyroid hormone receptors in living cells visualized using a receptor green fluorescent protein chimera. J. Biol. Chem. 1998, 273:27058-27063.
163. Zilliacus J., Carlstedt-Duke J., Gustafsson J.A., Wright A.P. Evolution of distinct DNA-binding specificities within the nuclear receptor family of transcription factors. Proc. Natl Acad. Sci. USA 1994, 91:4175-4179.